ALZPROTECT
AlzProtect is a biopharmaceutical company developing drug candidates from discovery to clinical trials for the treatment of neurodegenerative diseases including Alzheimer's disease (AD) and orphan tauopathies such as Progressive Supranuclear Palsy (PSP).
ALZPROTECT
Industry:
Biotechnology Clinical Trials Medical Pharmaceutical
Founded:
2007-01-01
Address:
Street, Maryland, United States
Country:
United States
Website Url:
http://www.alzprotect.com
Total Employee:
11+
Status:
Active
Total Funding:
20.2 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Google Font API Joomla!
Similar Organizations
Affinivax
Affinivax is a biopharmaceutical company developing vaccines that target infectious diseases.
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
OncBioMune
.OncBioMune is a biopharmaceutical company that develops medicines and vaccines to treat novel cancer and stimulate the immune system.
IVERIC bio
IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.
PaxVax
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Laurent Dupire CEO & General manager @ Alzprotect
CEO & General manager
2016-11-01
Philippe Verwaerde President and CSO @ Alzprotect
President and CSO
2009-12-01
Patricia Melnyk Co-Founder @ Alzprotect
Co-Founder
Founder
Investors List
Michael J. Fox Foundation
Michael J. Fox Foundation investment in Grant - Alzprotect
Xerys
Xerys investment in Series B - Alzprotect
Finovam Gestion
Finovam Gestion investment in Series A - Alzprotect
Nord France Amorcage
Nord France Amorcage investment in Series A - Alzprotect
Finorpa
Finorpa investment in Venture Round - Alzprotect
Eurasante
Eurasante investment in Non Equity Assistance - Alzprotect
Official Site Inspections
http://www.alzprotect.com Semrush global rank: 6.53 M Semrush visits lastest month: 1.05 K
- Host name: cluster011.ovh.net
- IP address: 213.186.33.40
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "Alzprotect"
Alzprotect - Homepage
Lille, France – December 5th, 2024 – Alzprotect, a pioneering biopharmaceutical company developing innovative treatments for neurodegenerative diseases, is pleased to announce the …See details»
Alzprotect - About the Company
Alzprotect develops drug candidates for the treatment of neurodegenerative diseases. Alzprotect is a biopharmaceutical company that develops drug candidates, from their discovery to clinical …See details»
Alzprotect - Crunchbase Company Profile & Funding
AlzProtect is a biopharmaceutical company developing drug candidates from discovery to clinical trials for the treatment of neurodegenerative diseases including Alzheimer's disease (AD) and …See details»
Alzprotect - Team
Professor Christian Bailly brings to Alzprotect substantial expertise in pharmaceutical research and life sciences, built over more than 30 years of experience. Currently an Associate …See details»
Alzprotect 2025 Company Profile: Valuation, Funding
Alzprotect General Information Description. Operator of a biotechnology company intended to specialize in neurodegeneration and tauopathies. The company …See details»
Alzprotect Overview | SignalHire Company Profile
Alzprotect is a private company that has been in the industry for 16 years. The company currently specializes in the Pharmaceuticals area. ... Organization Website: alzprotect.com : Alzprotect …See details»
AlzProtect Company Profile - Office Locations, Competitors ... - Craft
AlzProtect has 5 employees across 2 locations and $19.83 m in total funding,. See insights on AlzProtect including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Alzprotect SAS - LinkedIn
Alzprotect is a biopharmaceutical company that develops drug candidates, from their discovery to clinical trials, for the treatment of neurodegenerative diseases including Alzheimer’s disease ...See details»
AlzProtect SAS - Drug pipelines, Patents, Clinical trials - Synapse
Explore AlzProtect SAS with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, Drug:AZP-13005, AZP-7015, AZP-2006, Acetaminophen. Products. Data. Feature. ... The …See details»
Alzprotect - Partners
Life science cluster organization based in Flanders, Belgium. ... Expertise; AZP2006; News; Investors; Patients; Press; Alzprotect. 85 Rue Nelson Mandela 59120 Loos France Tel. +33 …See details»
ALZPROTECT - Eurasanté
Les travaux d’AlzProtect sont issus d’une collaboration de plusieurs années entre l’INSERM (Institut National de la Santé et de la Recherche Médicale) et l’Université Lille 2 Droit et Santé. Son produit phare, l’AZP2006 est …See details»
Alzprotect's Leadership Team Team - Team members and org …
Other teams at Alzprotect. View all +5. Board of Directors. 8 members. CEO and Executive Team. 2 members. Discover similar companies. Shortcut. Series B · New York, United States. …See details»
Alzprotect - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors ... Non Equity Assistance - …See details»
Alzprotect - Contacts, Employees, Board Members, Advisors
Alzprotect has 3 current employee profiles, including CEO & General manager Laurent Dupire. Laurent Dupire CEO & General manager Philippe Verwaerde President and CSOSee details»
Alzprotect - Accueil
Alzprotect Un potentiel thérapeutique exceptionnel, pour le traitement des tauopathies : Paralysie Supranucléaire Progressive (PSP) et maladie d’Alzheimer. Un mécanisme d’action original et …See details»
☑️Alzprotect — Consulting Organization from ... - DevelopmentAid
Alzprotect — Consulting Organization from France, has experience with The Seventh Framework Programme, it`s involved in Health, Laboratory & Measurement sectors. Our website uses …See details»
ALZPROTECT Receives Positive Feedback From EMA and FDA on …
Alzprotect plans to initiate a randomized Phase 2b/3 proof of concept for PSP and expand its drug development to include Parkinson’s disease, Alzheimer’s disease, and amyotrophic lateral …See details»
Alzprotect - Figures & Markets
Alzprotect raised a total of over 20 million euros, including 14 million € in 2017 to finance the conduct of a first phase 2 study to prove and measure the efficacy of AZP2006 in the …See details»
Alzprotect Announces Supportive Results from Open-Label …
Sep 18, 2024 Alzprotect remains committed to advancing AZP2006 through further clinical development, with the goal of providing a new therapeutic option for patients suffering from …See details»
Alzprotect - Pipeline
Alzprotect. 85 Rue Nelson Mandela 59120 Loos France Tel. +33 972 649 757. Contact. We use cookies on our website. Some of them are essential for the operation of the site, while others …See details»